Amgen (AMGN) Finished Goods (2013 - 2017)
Amgen (AMGN) posted quarterly Finished Goods of $1.1 billion for Q2 2017, down 4.57% quarter-over-quarter from $1.2 billion in Q1 2017.
Amgen (AMGN) Finished Goods (2013 - 2017) Analysis & Trends
Amgen's Finished Goods history runs 5 years deep, the most recent figure standing at $1.1 billion for Q2 2017.
- In Q2 2017, Finished Goods changed N/A year-over-year to $1.1 billion; the TTM figure through Jun 2017 stood at $1.1 billion (changed N/A YoY), while the FY2016 annual figure was $912.0 million, up 29.36% from the prior year.
- Finished Goods for Q2 2017 stood at $1.1 billion, down from $1.2 billion in the prior quarter.
- The five-year high for Finished Goods was $1.2 billion in Q1 2017, with the low at $705.0 million in Q4 2015.
- The 5-year median for Finished Goods is $914.0 million (2014), against an average of $920.5 million.
- The sharpest annual moves came in 2015 and 2017: Finished Goods decreased 21.49% in 2015, then soared 48.02% in 2017.
- Amgen's Finished Goods stood at $738.0 million in 2013, then gained by 21.68% to $898.0 million in 2014, then slipped by 21.49% to $705.0 million in 2015, then gained by 29.36% to $912.0 million in 2016, then increased by 21.27% to $1.1 billion in 2017.
- Business Quant data shows AMGN's Finished Goods at $1.1 billion in Q2 2017, $1.2 billion in Q1 2017, and $912.0 million in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.89 Bn | 632.13 Bn | 17.26 Bn |
| 2 | AbbVie | 470.43 Bn | 463.86 Bn | 12.70 Bn |
| 3 | Merck | 375.74 Bn | 368.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.99 Bn | 295.30 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.51 Bn | 252.61 Bn | 12.86 Bn |
| 6 | Amgen | 237.06 Bn | 223.07 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.88 Bn | 179.70 Bn | 6.22 Bn |
| 8 | Pfizer | 160.14 Bn | 148.44 Bn | 10.94 Bn |
| 9 | Gsk | 106.08 Bn | 101.91 Bn | 8.24 Bn |
| 10 | Sanofi | 55.21 Bn | 47.83 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 1.11 Bn |
| Mar 31, 2017 | 1.16 Bn |
| Dec 31, 2016 | 912.00 Mn |
| Mar 31, 2016 | 783.00 Mn |
| Dec 31, 2015 | 705.00 Mn |
| Sep 30, 2015 | 962.00 Mn |
| Jun 30, 2015 | 1.03 Bn |
| Dec 31, 2014 | 898.00 Mn |
| Jun 30, 2014 | 916.00 Mn |
| Dec 31, 2013 | 738.00 Mn |